Rosacea and the eye: a recent review

References

• Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):S27–S35. [Pub Med: 24229634]
   PubMed Web of Science ®Google Scholar
• Bakar O, Demircay Z, Toker E, et al. Ocular signs, symptoms and tear function tests of papulopustular rosacea paitents receiving azithromycin. J Euro Acad Dermatol Venereol. 2009;23:544–549. [Pub Med: 19250326]
   PubMed Web of Science ®Google Scholar
• Vieira ACC, Hofling-Lima AL, Mannis MJ. Ocular rosacea - a review. Arq Bras Oftalmol. 2012;75:363–369. [Pub Med: 23471336]
   PubMed Web of Science ®Google Scholar
• Browning DJ, Rosasenwasser G, Lugo M. Ocular rosacea in blacks. Am J Ophthalmol. 1986;101:441–444. [Pub Med: 2938475]
   PubMed Web of Science ®Google Scholar
• Spoendlin J, Voegel JJ, Jick SS, et al. A study of the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167:598–605. [Pub Med: 22564022]
   PubMed Web of Science ®Google Scholar
• Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584–587. [Pub Med: 11907512]
   PubMed Web of Science ®Google Scholar
• Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2017. DOI:10.1016/j.jaad.2017.08.037:1-8.
   Web of Science ®Google Scholar
• Tan J, Blume-Peytavi U, Ortonne JP, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Brt J Dermatol. 2013;169:555–562. [Pub Med: 23600367]
   PubMed Web of Science ®Google Scholar
• Liang H, Randon M, Michee S, et al. In vivo confocal microscopy evaluation of ocular and cutaneous alterations in patients with rosacea. Br J Ophthalmol. 2017;101:268–274. [Pub Med: 27222243]
   PubMed Web of Science ®Google Scholar
• Ghanem VC, Vehra N, Wong S, et al. The prevalence of ocular signs in acne rosacea: comparing patients from ocular and dermatology clinics. Cornea. 2003;22:230–233. [Pub Med: 12658088]
   PubMed Web of Science ®Google Scholar
• Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf. 2009;7:S1–S14. [Pub Med: 11507337]
   PubMed Web of Science ®Google Scholar
• Denton P, Barequest IS, O’Brien TP. Therapy of infectious Blepharitis. Ophthalmol Clin NA. 1999;12:9–14.
   Google Scholar
• Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107–126. [Pub Med: 17075643]
   PubMedGoogle Scholar
• Faraj HG, Hoang-Xuan T. Chronic cicatrizing conjunctivitis. Curr Opin Ophthalmol. 2001;12:250–257. [Pub Med: 11507337]
   PubMed Web of Science ®Google Scholar
• Akpek EK, Merchant A, Pinar V, et al. Ocular rosacea: patient characteristics and follow up. Ophthalmology. 1997;104:1863–1867. [Pub Med: 9373118]
   PubMed Web of Science ®Google Scholar
• Starr PA, McDonald A. Oculocutaneous aspects of rosacea. Proc Royal Soc Med. 1969;62:9–11. [Pub Med: 4236661]
   PubMedGoogle Scholar
• Al Arfaj K, Al Zamil W. Spontaneous corneal performation in ocular rosacea. Middle East Afr J Ophthalmol. 2010;17:186–188. [Pub Med: 20616930]
   PubMedGoogle Scholar
• Lemp MA, Hamil JR. Factors affecting tear breakup in normal eyes. Arch Ophthalmol. 1973;89:103–105. [Pub Med: 4683600]
   PubMed Web of Science ®Google Scholar
• Quarterman MJ, Johnson DW, Abele DC, et al. Ocular rosacea: signs, symptoms and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997;133:49–54. [Pub Med: 9006372]
   PubMedGoogle Scholar
• Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930–1937. [Pub Med: 21450914]
   PubMed Web of Science ®Google Scholar
• Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15:802–812. [Pub Med: 28797892]
   PubMed Web of Science ®Google Scholar
• Webster GF, Durrani K, Suchecki J. Ocular rosacea, psoriasis and lichen planus. Clinics Dermatol. 2016;34:146–150. [Pub Med: 26903182]
   PubMed Web of Science ®Google Scholar
• Abdelfattah NS, Dastridou A, Sadda SR, et al. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea. 2015;34 Suppl 1:S48–S52. [Pub Med: 26226477]
   Web of Science ®Google Scholar
• Karpouzis A, Avgeridis P, Tripsianis G, et al. Assessment of tachykinin receptor 3ʹ gene polymorphism rs3733631 in rosacea. Int Sch Res Notices. 2015;2015:469402. [Pub Med: 27347521]
   PubMedGoogle Scholar
• Chang ALS, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Invest Dermatol. 2015;135:1548–1555. [Pub Med: 25695682]
   PubMed Web of Science ®Google Scholar
• Oge’ L, Muncie H, Phillips-Savoy A. Rosacea: diagnosis and treatment. Am Fam Physician. 2015;92:187–196. [Pub Med: 26280139]
   PubMed Web of Science ®Google Scholar
• Melnik BC. Endoplasmic reticiulum stress: key promoter of rosacea pathogenesis. Exp Dermatol. 2014;23:868–873. [Pub Med: 25047092]
   PubMed Web of Science ®Google Scholar
• Cribier B. Rosacea under the microscope: characteristic histological findings. J Euro Acad Dermatol Venereol. 2013;27:1336–1343. [Pub Med: 23451732]
   PubMed Web of Science ®Google Scholar
• Forton F, Seys B. Density of Demodex folliculorum in rosacea: A case control study using standardized biopsy. Br J Dermatol. 1993;128:650–659. [Pub Med: 21383982]
   PubMed Web of Science ®Google Scholar
• Koller B, Muller-Wiefel AS, Rupec R, et al. Chitin modulates innate immune responses of keratinocytes. PLoS One. 2011;6:e16594. [Pub Med: 21383982]
   PubMed Web of Science ®Google Scholar
• Lacey N, Delaney S, Kavanagh K, et al. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol. 2007;157:474–481. [Pub Med: 17596156]
   PubMed Web of Science ®Google Scholar
• Li J, O’Reilly N, Sheha H, et al. Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus proteins in patients with Facial rosacea. Ophthalmology. 2010;117:870–877. [Pub Med: 20079929]
   PubMed Web of Science ®Google Scholar
• Heath WR, Carbone FR. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol. 2013;14:978–985. [Pub Med: 24048119]
   PubMed Web of Science ®Google Scholar
• Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol. 2004;4:211–222. [Pub Med: 15039758]
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Gallo RL. Rosacea as a disease of cathelcidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15:12–15. [Pub Med: 22076322].
   PubMedGoogle Scholar
• Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011;131:688–697. [Pub Med: 23171449]
   PubMed Web of Science ®Google Scholar
• Casas C, Paul C, Lahfa M, et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012;21:906–910. [Pub Med: 22076326]
   PubMed Web of Science ®Google Scholar
• Ueta M. Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea. 2008;27 Suppl 1:S31–S40. [Pub Med: 18813073]
   PubMed Web of Science ®Google Scholar
• Ueta M, Kinoshita S. Innate immunity of the ocular surface. Brain Res Bulletin. 2010;81:219–228.
   PubMed Web of Science ®Google Scholar
• Ueta M, Kinoshita S. Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res. 2012;31:551–575. [Pub Med: 22728145]
   PubMed Web of Science ®Google Scholar
• Ueta M, Hamuro J, Kiyono H, et al. Triggering o TLR3 by polyl: cin human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun. 2005;331:285–294. [Pub Med: 15845391]
   PubMed Web of Science ®Google Scholar
• Gerber PA, Buhren BA, Steinhoff M, et al. Rosacea: the cytokine and chemokine network. J Investig Dermatol Symp Proc. 2011;15:40–47. [PubMed:22295065]
   PubMedGoogle Scholar
• Segovia J, Sabbah A, Mgbemena V, et al. TLR2/MyD88/NF-kB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One. 2012;7:e29695. [Pub Med: 10514489]
   PubMed Web of Science ®Google Scholar
• Redfern RL, Reins RY, McDermott AM. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res. 2011;92:209–220. [Pub Med: 21195713]
   PubMed Web of Science ®Google Scholar
• Brattsand M, Egelrud T. Purification, molecular cloning and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem. 1999;274:30033–30040. [Pub Med: 15675955]
   PubMed Web of Science ®Google Scholar
• Ishida-Yamamato A, Deraison C, Bonnart C, et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol. 2005;124:360–366. [Pub Med: 25890455]
   PubMed Web of Science ®Google Scholar
• Two AM, Wu W, Gallo RL, et al. Rosacea: part I. Introduction, categorization, histology, pathogenesis and risk factors. J Am Acad Dermatol. 2015;72:749–758. [Pub Med: 22336948]
   PubMed Web of Science ®Google Scholar
• Kanada K, Nakatsuji T, Gallo RL. Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin. J Invest Dermatol. 2012;132:1435–1442. [Pub Med: 1695500].
   PubMed Web of Science ®Google Scholar
• Lundstrom A, Egelrud T. Cell shedding from human plantar skin in vitro: evidence of its dependence on endogenous proteolysis. J Invest Dermatol. 1988;91:340–343. [Pub Med: 3049831]
   PubMed Web of Science ®Google Scholar
• Park K, Elias PM, Oda Y, et al. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem. 2011;286:34121–34130. Pub Med: 21832078]
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Dinardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975–980. [Pub Med: 17676051].
   PubMed Web of Science ®Google Scholar
• Scott MG, Davidson DJ, Gold MR, et al. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol. 2002;169:3883–3891. [Pub Med: 12244186]
   PubMed Web of Science ®Google Scholar
• Xhindoli D, Pacor S, Benincasa M, et al. The human cathelicidin LL-37–A pore-forming antibacterial peptide and host-cell modulator. Biochem Biophys Acta. 2016;1858:546–566. [Pub Med: 26556394]
   PubMed Web of Science ®Google Scholar
• Braff MH, Dinardo A, Gallo RL. Keratinocytes store the antimicrobial peptpide cathelicidin in lamellar bodies. J Invest Dermatol. 2005;124:394–400. [Pub Med: 15675959]
   PubMed Web of Science ®Google Scholar
• Schauber J, Gallo RL. The vitamin D pathway: a new target for control of the skin’s immune response? Exp Dermatol. 2008;17:633–639. [Pub Med: 18573153].
   PubMed Web of Science ®Google Scholar
• Peric C, Lehmann B, Vashina G, et al. UV-B-triggered induction of vitamin D3 metabolism differentially affects antimicrobial peptide expression in keratinocytes. J Allergy Clin Immunol. 2010;125:746–749. [Pub Med: 20226307]
   PubMed Web of Science ®Google Scholar
• Sakabe J, Umayahara T, Hiroike M, et al. Calcipotriol increases hCAP18 mRNA expression but inhibits extracellular LL37 peptide production in IL-17/IL-22-stimulated normal human epidermal keratinocytes. Acta Derm Venereol. 2014;94:512–516. [Pub Med: 24419155]
   PubMed Web of Science ®Google Scholar
• Buhl T, Silk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways. J Invest Dermatol. 2015;135:2198–2208. [Pub Med: 25848978].
   PubMed Web of Science ®Google Scholar
• Kim M, Kim K-E, Jung HY, et al. Recombinant erythroid differentiation regulator 1 inhibits both inflammation and angiogenesis in a mouse model of rosacea. Exp Dermatol. 2015;24:680–685. [Pub Med: 25940661]
   PubMed Web of Science ®Google Scholar
• Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol. 2003;170:2274–2278. [Pub Med: 12594247]
   PubMed Web of Science ®Google Scholar
• Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. J Invest Dermatol. 2014;134:2728–2736. [Pub Med: 24844861].
   PubMed Web of Science ®Google Scholar
• Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol. 2007;82:1375–1381. [Pub Med: 17709402]
   PubMed Web of Science ®Google Scholar
• Taylor JL, Hattle JM, Dreitz SA, et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun. 2006;74:6135–6144. [Pub Med: 16982845]
   PubMed Web of Science ®Google Scholar
• Jang YH, Sim JH, Kang HY, et al. Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea. J Eur Acad Dermatol Venereol. 2011;25:544–548. [Pub Med: 20698913]
   PubMed Web of Science ®Google Scholar
• Wlaschek M, Bolsen K, Herrmann G, et al. UVA-induced autocrine stimulation of fibroblast-derived-collagenase of IL-6: a possible mechanism in dermal photodamage. J Invest Dermatol. 1993;101:164–168. [Pub Med: 7688402]
   PubMed Web of Science ®Google Scholar
• Jones D. Reactive oxygen species and rosacea. Cutis. 2004;74(3 Suppl):17-20, 32-34. [Pub Med: 15499754]
   PubMed Web of Science ®Google Scholar
• Palamar M, Degirmenci C, Ertam I, et al. Ocular response analyzer measurements and central corneal thickness in ocular rosacea patients. Int Ophthalmol. 2017;37:7–11. [Pub Med: 26971098]
   PubMed Web of Science ®Google Scholar
• O’Reilly N, Gallagher C, Reddy Katikireddy K, et al. Demodex associated Bacillus proteins induce an aberrant wound healing response in a corneal epithelial cell line: possible implications for corneal ulcer formation in ocular rosacea. Invest Ophthalmol Vis Sci. 2012;53:3250–3259. [Pub Med: 22531699]
   PubMed Web of Science ®Google Scholar
• McMahon F, Banville N, Bergin DA, et al. Activation of neutrophils via IP3 pathway following exposure to Demodex-associated bacterial proteins. Inflammation. 2016;39:425–433. [Pub Med: 26433579]
   PubMed Web of Science ®Google Scholar
• Wladis EJ, Iglesias BV, Adam AP, et al. Molecular biologic assessment of cutaneous specimens of ocular rosacea. Ophthal Plast Reconstr Surg. 2012;28:246–250. [Pub Med: 22617640]
   PubMed Web of Science ®Google Scholar
• Wladis EJ, Carlson JA, Wang MS, et al. Toll-like receptors and vascular markers in ocular rosacea. Ophthal Plast Reconstr Surg. 2013;29:290–293. [Pub Med: 23839635]
   PubMed Web of Science ®Google Scholar
• Seeliger S, Buddenkotte J, Schmidt-Choudhury A, et al. Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo. Am J Pathol. 2010;177:2563–2575. [Pub Med: 20889562]
   PubMed Web of Science ®Google Scholar
• Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150:1136–1141. [Pub Med: 15214900]
   PubMed Web of Science ®Google Scholar
• Narayanan S, Hunerbein A, Getie M, et al. Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system. J Pharm Pharmcol. 2007;59:1125–1130. [Pub Med: 17725855]
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother. 2004;5:5–13. [Pub Med: 14680431]
   PubMed Web of Science ®Google Scholar
• Coda A, Hata T, Miller J, et al. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013;69:570–577. [Pub Med: 23871720]
   PubMed Web of Science ®Google Scholar
• Fowler J, Jarratt M, Moore A, et al. Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol. 2012;166:633–641. [Pub Med: 22050040]
   PubMed Web of Science ®Google Scholar
• Fowler J Jr., Jackson M, Moore A, et al. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. J Drugs Dermatol. 2013;12:650–656. [Pub Med: 23839181]
   PubMed Web of Science ®Google Scholar
• Liu PT, Krutzik SR, Kim J, et al. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol. 2005;174:2467–2470. [Pub Med: 15728448]
   PubMed Web of Science ®Google Scholar
• Gupta AK, Chow M. Pimecrolimus: a review. J Euro Acad Dermatol Venereol. 2003;17:493–503. [Pub Med: 12941081]
   PubMed Web of Science ®Google Scholar
• Grassberger M, Steinhoff M, Schneider D, et al. Pimecrolimus – an anti-inflammatory drug targeting the skin. Exp Dermatol. 2004;13:721–730. [Pub Med: 15560755]
   PubMed Web of Science ®Google Scholar
• Deeks ED. Ivermectin: a review in rosacea. Am J Clin Dermatol. 2015;16:447–452. [Pub Med: 26254001]
   PubMed Web of Science ®Google Scholar
• Webster W, Del Ross JQ. Anti-inflammatory activity of tetracyclines. Dermatol Clin. 2007;25:133–135. [Pub Med: 17430750]
   PubMed Web of Science ®Google Scholar
• Korting HC, Schollman C. Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol. 2009;22:287–294. [Pub Med: 19786821]
   PubMed Web of Science ®Google Scholar
• Wise RD. Submicrobial doxycycline and rosacea. Compr Ther. 2007;33:78–81. [Pub Med: 18004018]
   PubMedGoogle Scholar
• Van Der Linden MMD, Van Ratingen AR, Van Rappard DC, et al. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety. Br J Dermatol. 2017;176:1465–1474. [Pub Med: 17797396]
   PubMed Web of Science ®Google Scholar
• Craige H, Cohen JB. Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol. J Am Acad Dermatol. 2005;53:881–884. [Pub Med: 16243148]
   PubMed Web of Science ®Google Scholar
• Dipenza MC, Wolpert EB, Gilliland KL, et al. Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol. 2012;132:2198–2205. [Pub Med: 22513780]
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Gallo RL, Tanghetti E, et al. An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. Cutis. 2013;91(3Suppl):1–8. [Pub Med: 23833998]
   PubMedGoogle Scholar